A recent study suggests that the standard method for measuring cholesterol may be failing millions of patients. Researchers have found that testing for apolipoprotein B (apoB), a protein found on all potentially harmful cholesterol particles, provides a more accurate assessment of cardiovascular risk than the traditional LDL cholesterol test.
Better Accuracy for Heart Health
The study highlights that apoB testing is superior for determining which individuals require more intensive medical intervention. By measuring the total number of atherogenic particles rather than just the volume of cholesterol within them, doctors can better predict and prevent adverse events.
Cost-Effective Prevention
Beyond clinical accuracy, the findings indicate that adopting apoB testing could be highly beneficial for the U.S. healthcare system. The research suggests that implementing this test on a wider scale could prevent a significant number of heart attacks and strokes while remaining a cost-effective alternative to current diagnostic standards.
